Home › Funds › Ally Bridge Group (NY) LLC › SLDB
Ally Bridge Group (NY) LLC position in SLDB
SOLID BIOSCIENCES INC COM NEW · Health Care
Ally Bridge Group (NY) LLC reported holding 255,959 shares of SLDB (SOLID BIOSCIENCES INC COM NEW) in its Q2 2026 13F filing — a position valued at US$2.6M, representing 2.26% of its reported portfolio and ranking #15 among its reported holdings. Ally Bridge Group (NY) LLC has disclosed SLDB holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Ally Bridge Group (NY) LLC's SLDB position evolved
Ally Bridge Group (NY) LLC first disclosed a stake in SLDB in Q2 2025 at 724,000 shares (US$3.5M). The position peaked in Q1 2026 at 766,974 shares, worth US$5.5M. Across 5 filings, Ally Bridge Group (NY) LLC increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 255,959 shares valued at US$2.6M — a reduction of -511,015 shares quarter over quarter.. Notable position changes include a 85% increase in Q1 2026 (shares rose 39% over the following quarter), a 67% trim in Q2 2026 (shares fell 28% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 724.00K | $3.53M | New |
| Q3 2025 | 549.18K | $3.39M | Reduce |
| Q4 2025 | 413.62K | $2.33M | Reduce |
| Q1 2026 | 766.97K | $5.52M | Add |
| Q2 2026 | 255.96K | $2.56M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SLDB and 13F data
SLDB (SOLID BIOSCIENCES INC COM NEW) is a Health Care company. 48 other funds we track also report a position in SLDB — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$120.2M), PERCEPTIVE ADVISORS LLC (US$118.9M), Bain Capital Life Sciences Investors, LLC (US$98.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SLDB
- RA CAPITAL MANAGEMENT, L.P. 12.04M sh · $120.24M · Q2 2026
- PERCEPTIVE ADVISORS LLC 11.91M sh · $118.95M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 9.81M sh · $97.99M · Q2 2026
- Siren, L.L.C. 7.69M sh · $76.83M · Q2 2026
- ARMISTICE CAPITAL, LLC 4.28M sh · $42.74M · Q2 2026
- Deep Track Capital, LP 3.57M sh · $35.61M · Q2 2026
- Vestal Point Capital, LP 2.16M sh · $21.58M · Q2 2026
- Redmile Group, LLC 1.95M sh · $19.47M · Q2 2026
- SILVERARC CAPITAL MANAGEMENT, LLC 668.45K sh · $6.68M · Q2 2026
- Birchview Capital, LP 666.20K sh · $6.66M · Q2 2026
- Monashee Investment Management LLC 500.00K sh · $5.00M · Q2 2026
- STEMPOINT CAPITAL LP 358.78K sh · $3.58M · Q2 2026
More on Ally Bridge Group (NY) LLC
FAQ
How long has Ally Bridge Group (NY) LLC held SLDB?
Ally Bridge Group (NY) LLC has disclosed SLDB holdings in 5 of the last 5 reported quarters, going back to Q2 2025.
What is Ally Bridge Group (NY) LLC's current position in SLDB?
As of Q2 2026, Ally Bridge Group (NY) LLC holds 255.96K shares of SLDB (SOLID BIOSCIENCES INC COM NEW), valued at $2.56M, representing 2.26% of its reported portfolio and ranking #15.
Has Ally Bridge Group (NY) LLC been buying or selling SLDB?
In the latest 13F filing (Q2 2026), Ally Bridge Group (NY) LLC reduced its position in SLDB. The position peaked in Q1 2026 at 766.97K shares.
Which other funds hold SLDB?
Other major institutional holders of SLDB include RA CAPITAL MANAGEMENT, L.P., PERCEPTIVE ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.